Articles tagged with Withdrawal Symptoms
A systematic review found that serotonin-noradrenaline reuptake inhibitors can cause withdrawal symptoms when discontinued, with venlafaxine showing higher prevalence rates. These symptoms typically occur within a few days of stopping the medication and can last several weeks.
A mouse study found that metformin blocks symptoms of nicotine withdrawal in rodents, eliminating anxiety and negative effects. The diabetes drug appears to activate AMPK, a pathway stimulated by chronic nicotine use, reducing withdrawal symptoms.
New research reveals exercise during nicotine exposure decreases withdrawal symptoms by activating α7 nicotinic acetylcholine receptors in the brain. This protective effect may aid smoking cessation by reducing withdrawal severity and promoting recovery.
Researchers at Washington State University have found that hyperbaric oxygen therapy can relieve opioid withdrawal symptoms in mice, with a significant reduction in severe withdrawal signs. The study suggests implications for treating heroin addiction and could lead to new clinical evidence supporting FDA approval for the treatment.
A new study found that treating withdrawal symptoms can help cannabis users quit, with 85% of participants relapsing within 16 days. The study also showed that people who experienced withdrawal symptoms had difficulty staying abstinent, highlighting the need for immediate treatment.
A new study led by American University professor Laura M. Juliano found that brief cognitive-behavioral therapy can significantly reduce caffeine consumption in individuals with problematic caffeine use, with an average decrease of 77%, and most participants reduced their daily intake to below 200mg.
Studies suggest that the insular cortex, damaged during a stroke, can lead to increased likelihood of quitting smoking and reduced withdrawal symptoms. Smokers who experienced strokes in this area were almost twice as likely to quit smoking compared to those with strokes in other parts of the brain.
Researchers found that brain activity increases with smoking, but quickly adapts after quitting. Stopping smoking abruptly can lead to severe withdrawal symptoms, which may deter former smokers from continuing their quit journey.
A study by Massachusetts General Hospital found that 40% of cannabis-using adolescents experienced withdrawal symptoms, despite widespread perception of cannabis as nonaddictive. The presence or absence of withdrawal did not affect long-term treatment outcomes.
A recent study published in PLOS ONE found that certain cannabis withdrawal symptoms are more strongly associated with relapse than others. Participants experiencing physical tension, sleep problems, and anxiety were more likely to relapse during the abstinence period and consumed more cannabis afterwards.
A new Australian study reveals a significant rise in neonatal withdrawal syndrome among newborns, with 906 cases diagnosed between 1980 and 2005. The research highlights the need for early identification and intervention to prevent abuse and neglect.
A study by Johns Hopkins Medicine finds that marijuana withdrawal is similar to tobacco withdrawal, with common symptoms like irritability and trouble sleeping. The research suggests that clinicians treating marijuana addiction should consider these effects in their practice.
Two new vaccines have been designed to combat cocaine and methamphetamine dependencies, stimulating the body to produce antibodies that attack the drugs. These therapeutic vaccines minimize withdrawal symptoms and relieve addiction, but do not necessarily curb relapse.
A short walk can significantly reduce cravings for cigarettes in smokers, helping them manage withdrawal symptoms and resist the urge to smoke. Moderate exercise can be as effective as a drug in reducing cravings and withdrawal symptoms, making it a valuable tool for quitting smoking.
Researchers found that disrupting the brain's stress-response mechanism exacerbates behavioral withdrawal symptoms in mice. Administering corticosterone alleviates these symptoms, suggesting new approaches to reduce withdrawal symptoms. Genetic changes indicate impaired stress-response circuitry in the brain.
Researchers found that nicotine withdrawal symptoms begin as early as 30 minutes after quitting, impacting smokers' cravings, mood, and behavior. This discovery challenges the common assumption that withdrawal symptoms occur later in the process.
Researchers studying neonatal rat models aim to understand the role of norepinephrine in opiate withdrawal and explore its potential as a treatment. Clonidine, traditionally used for high blood pressure, may provide relief from symptoms in newborn infants.
A study of 72 adolescent marijuana users found that nearly two-thirds experienced four or more symptoms of marijuana withdrawal, including anxiety and irritability. The majority of participants also reported experiencing some withdrawal symptoms after abruptly stopping daily or near-daily use.
Researchers validated five clusters of common withdrawal symptoms: headache, fatigue, dysphoric mood, difficulty concentrating, and flu-like symptoms. A stepwise approach can eliminate severe withdrawal symptoms by gradually reducing caffeine consumption.
A recent study found that stress affects men and women differently when it comes to nicotine addiction and relapse. Women experience greater emotional side effects, while men struggle with biological changes during abstinence. The study also revealed that cortisol levels play a crucial role in triggering cravings and withdrawal symptoms.
A study found that bupropion significantly reduced withdrawal symptoms and increased abstention rates from smoking. The medication also decreased negative mood in participants, which was more strongly related to relapse.
A study by Scott Coffey found that cocaine withdrawal symptoms are relatively mild and decrease steadily over time, with improvements in depression, anxiety, and energy levels.
Researchers have found surprising variation in nicotine withdrawal symptoms, with many experiencing intense spikes months after quitting. The study suggests that the duration or pattern of withdrawal symptoms is more difficult to overcome than the initial intensity.
A case study published in JAMA reports a patient experiencing severe withdrawal symptoms after stopping valerian supplements. The researchers emphasize the importance of asking patients about herbal product use and providing open-minded care to address potential side effects and interactions.